AANS/CNS Section on Tumors I - Precision Medicine for Meningiomas

Tuesday, April 16 | 2:30 pm - 6:00 pm | 30CDE; SDCC

Moderator(s): Vijay Agarwal, MD; Vincent Anthony DiNapoli, MD; Michael Edward Ivan, MD; Isaac Yang, MD, FAANS

Add to Calendar Tuesday, April 16 Tuesday, April 16 America/Los_Angeles AANS/CNS Section on Tumors I - Precision Medicine for Meningiomas 30CDE; SDCC

Supported by an educational grant from Varian Medical Systems

2:30 pm - 2:34 pm

Introduction to Session: Precision Medicine for Meningiomas

Speaker: Michael Edward Ivan, MD

4/16/2019 2:30:00 PM 4/16/2019 2:34:00 PM America/Los_Angeles Introduction to Session: Precision Medicine for Meningiomas 30CDE; SDCC

2:35 pm - 2:50 pm

Mutational Landscape of Benign and  Aggressive Meningiomas

Speaker: Ian F. Dunn, MD, FAANS

4/16/2019 2:35:00 PM 4/16/2019 2:50:00 PM America/Los_Angeles Mutational Landscape of Benign and  Aggressive Meningiomas 30CDE; SDCC

2:51 pm - 3:06 pm

Clinical Trial Update – Precision Medicine for Meningiomas

Speaker: Priscilla Kaliopi Brastianos, MD

4/16/2019 2:51:00 PM 4/16/2019 3:06:00 PM America/Los_Angeles Clinical Trial Update – Precision Medicine for Meningiomas 30CDE; SDCC

3:07 pm - 3:22 pm

Radiation of Atypical Meningiomas

Speaker: Michael W. McDermott, MD, FAANS

4/16/2019 3:07:00 PM 4/16/2019 3:22:00 PM America/Los_Angeles Radiation of Atypical Meningiomas 30CDE; SDCC

3:23 pm - 3:38 pm

Point-Counter Point: Leaving Residual Meningioma: No Big Deal or Cardinal Sin

Speaker: Jacques J. Morcos, MD, FAANS

4/16/2019 3:23:00 PM 4/16/2019 3:38:00 PM America/Los_Angeles Point-Counter Point: Leaving Residual Meningioma: No Big Deal or Cardinal Sin 30CDE; SDCC

3:39 pm - 3:54 pm

Point-Counter Point: Leaving Residual Meningioma: No Big Deal or Cardinal Sin

Speaker: William T. Couldwell, MD, PhD, FAANS

4/16/2019 3:39:00 PM 4/16/2019 3:54:00 PM America/Los_Angeles Point-Counter Point: Leaving Residual Meningioma: No Big Deal or Cardinal Sin 30CDE; SDCC

3:55 pm - 4:30 pm

Beverage Break in the Exhibit Hall

4/16/2019 3:55:00 PM 4/16/2019 4:30:00 PM America/Los_Angeles Beverage Break in the Exhibit Hall 30CDE; SDCC

4:31 pm - 4:40 pm

341. Targeting The CSF1/CSF1R Axis is an Effective Treatment Strategy for Malignant Meningiomas
Features NREF-funded Author

Presenting Author: Jacky Yeung, MD

4/16/2019 4:31:00 PM 4/16/2019 4:40:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=45923" style="text-decoration : none; font-weight:700">341. Targeting The CSF1/CSF1R Axis is an Effective Treatment Strategy for Malignant Meningiomas </a><br> <i>Features NREF-funded Author</i><span><img src="/Includes/AANS/AN19/Images/Torch.svg" style="height:33px;width:auto;display:inline-block;margin:5px;"/></span> 30CDE; SDCC

4/16/2019 4:41:00 PM 4/16/2019 4:50:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=45889"><strong>342. Genetic variation of recurrent low-grade and high-grade meningiomas is associated with clinical outcomes and progression-free survival: An analysis of 150 meningiomas with complete genomic sequencing</strong></a> 30CDE; SDCC

4:51 pm - 5:00 pm

4/16/2019 4:51:00 PM 4/16/2019 5:00:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=45853"><strong>343. Genetic Signatures of Skull Base Chordoma Progression after Surgery and Radiation</strong></a> 30CDE; SDCC

4/16/2019 5:01:00 PM 4/16/2019 5:10:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=45810"><strong>344. Results of a Prospective Multicenter Controlled Study Comparing Pituitary Gland Hormone Outcomes of Microscopic versus Fully Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas</strong></a> 30CDE; SDCC

5:11 pm - 5:20 pm

4/16/2019 5:11:00 PM 4/16/2019 5:20:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=46171" style="text-decoration : none; font-weight:700">345. Decreased Function of Isoprenylcysteine Carboxylmethyltransferase Function Results in Increased Sensitivity to Chemoradiation</a><br> <i>Features NREF-funded Author</i><span><img src="/Includes/AANS/AN19/Images/Torch.svg" style="height:33px;width:auto;display:inline-block;margin:5px;"/></span> 30CDE; SDCC

5:21 pm - 5:30 pm

4/16/2019 5:21:00 PM 4/16/2019 5:30:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=45967"><strong>346. Immune Monitoring with CyTOF in Peptide Vaccine Therapy for Low-Grade Glioma</strong></a> 30CDE; SDCC

5:31 pm - 5:40 pm

347. Development and validation of an individualized predictor of meningioma recurrence
Features NREF-funded Author

Presenting Author: Farshad Nassiri, MD (Canada)

4/16/2019 5:31:00 PM 4/16/2019 5:40:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=46137" style="text-decoration : none; font-weight:700">347. Development and validation of an individualized predictor of meningioma recurrence</a><br> <i>Features NREF-funded Author</i><span><img src="/Includes/AANS/AN19/Images/Torch.svg" style="height:33px;width:auto;display:inline-block;margin:5px;"/></span> 30CDE; SDCC

4/16/2019 5:41:00 PM 4/16/2019 5:50:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=46091"><strong>348. Tumor-Specific Super-Enhancers Span Multiple Novel Therapeutic Targets in Meningioma</strong></a> 30CDE; SDCC

5:51 pm - 6:00 pm

4/16/2019 5:51:00 PM 4/16/2019 6:00:00 PM America/Los_Angeles <a href="./Eposter?eventid=48888&itemid=TUMOR_I_SECTION&propid=45948" style="text-decoration : none; font-weight:700">349. Cost-effectiveness of Endoscopic versus Microscopic Transsphenoidal Surgery for Pituitary Adenomas</a><br> <i>Features NREF-funded Author</i><span><img src="/Includes/AANS/AN19/Images/Torch.svg" style="height:33px;width:auto;display:inline-block;margin:5px;"/></span> 30CDE; SDCC